Lower dose of newer clot-buster may be appropriate for some stroke patients

(American Heart Association) In a comparison of 0.25mg/kg and 0.40mg/kg doses of the newer and more convenient clot-busting medication tenecteplase, there was no advantage in increasing the dose above 0.25mg/kg in stroke patients who planned to have mechanical clot retrieval.In addition, administering tenecteplase may decrease the need for mechanical clot removal.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news